HPA Axis Interactions with Behavioral Systems

Overview

Journal Compr Physiol

Specialty Physiology

Date 2016 Oct 27

PMID 27783863

Citations 33

Authors

Amy E B Packard

Ann E Egan

Yvonne M Ulrich-Lai

Affiliations

Soon will be listed here.

Abstract

Perhaps the most salient behaviors that individuals engage in involve the avoidance of aversive experiences and the pursuit of pleasurable experiences. Engagement in these behaviors is regulated to a significant extent by an individual's hormonal milieu. For example, glucocorticoid hormones are produced by the hypothalamic-pituitary-adrenocortical (HPA) axis, and influence most aspects of behavior. In turn, many behaviors can influence HPA axis activity. These bidirectional interactions not only coordinate an individual's physiological and behavioral states to each other, but can also tune them to environmental conditions thereby optimizing survival. The present review details the influence of the HPA axis on many types of behavior, including appetitively-motivated behaviors (e.g., food intake and drug use), aversively-motivated behaviors (e.g., anxiety-related and depressive-like) and cognitive behaviors (e.g., learning and memory). Conversely, the manuscript also describes how engaging in various behaviors influences HPA axis activity. Our current understanding of the neuronal and/or hormonal mechanisms that underlie these interactions is also summarized. © 2016 American Physiological Society. Compr Physiol 6:1897-1934, 2016.

Citing Articles

Pituitary adenylyl cyclase-activating polypeptide modulates the stress response: the involvement of different brain areas and microglia.

Singh A, Shim P, Naeem S, Rahman S, Lutfy K Front Psychiatry. 2025; 15:1495598.

PMID: 39931196 PMC: 11807976. DOI: 10.3389/fpsyt.2024.1495598.

Endocrine Disrupting Toxicity of Bisphenol A and Its Analogs: Implications in the Neuro-Immune Milieu.

Buoso E, Masi M, Limosani R, Oliviero C, Saeed S, Iulini M J Xenobiot. 2025; 15(1.

PMID: 39846545 PMC: 11755641. DOI: 10.3390/jox15010013.

Maternal Low-Protein Diet During Nursing Leads to Glucose-Insulin Dyshomeostasis and Pancreatic-Islet Dysfunction by Disrupting Glucocorticoid Responsiveness in Male Rats.

Mathias P, Dantas Rodrigues A, Lisboa P, Miranda R, Malta A, Ribeiro T Biology (Basel). 2025; 13(12.

PMID: 39765703 PMC: 11673749. DOI: 10.3390/biology13121036.

Assessing the Influence of Low Doses of Sucrose on Memory Deficits in Fish Exposed to Common Insecticide Based on Fipronil and Pyriproxyfen.

Rarinca V, Hritcu L, Burducea M, Plavan G, Lefter R, Burlui V Curr Issues Mol Biol. 2024; 46(12):14168-14189.

PMID: 39727976 PMC: 11674115. DOI: 10.3390/cimb46120848.

Corticosteroid-Induced Psychiatric Disorders: Mechanisms, Outcomes, and Clinical Implications.

Nasereddin L, Alnajjar O, Bashar H, Abuarab S, Al-Adwan R, Chellappan D Diseases. 2024; 12(12).

PMID: 39727630 PMC: 11675195. DOI: 10.3390/diseases12120300.

References

Matta S, Beyer H, McAllen K, Sharp B . Nicotine elevates rat plasma ACTH by a central mechanism. J Pharmacol Exp Ther. 1987; 243(1):217-26. View

Caggiula A, Epstein L, Antelman S, Saylor S, Knopf S, Perkins K . Acute stress or corticosterone administration reduces responsiveness to nicotine: implications for a mechanism of conditioned tolerance. Psychopharmacology (Berl). 1993; 111(4):499-507. DOI: 10.1007/BF02253543. View

Luksys G, Sandi C . Neural mechanisms and computations underlying stress effects on learning and memory. Curr Opin Neurobiol. 2011; 21(3):502-8. DOI: 10.1016/j.conb.2011.03.003. View

Miczek K, Mutschler N . Activational effects of social stress on IV cocaine self-administration in rats. Psychopharmacology (Berl). 1996; 128(3):256-64. DOI: 10.1007/s002130050133. View

Soravia L, Heinrichs M, Aerni A, Maroni C, Schelling G, Ehlert U . Glucocorticoids reduce phobic fear in humans. Proc Natl Acad Sci U S A. 2006; 103(14):5585-90. PMC: 1414637. DOI: 10.1073/pnas.0509184103. View

Groc L, Choquet D, Chaouloff F . The stress hormone corticosterone conditions AMPAR surface trafficking and synaptic potentiation. Nat Neurosci. 2008; 11(8):868-70. DOI: 10.1038/nn.2150. View

Helton D, Tizzano J, Monn J, Schoepp D, Kallman M . Anxiolytic and side-effect profile of LY354740: a potent, highly selective, orally active agonist for group II metabotropic glutamate receptors. J Pharmacol Exp Ther. 1998; 284(2):651-60. View

Rittmaster R, Cutler Jr G, Sobel D, Goldstein D, Koppelman M, Loriaux D . Morphine inhibits the pituitary-adrenal response to ovine corticotropin-releasing hormone in normal subjects. J Clin Endocrinol Metab. 1985; 60(5):891-5. DOI: 10.1210/jcem-60-5-891. View

Shalev U, Marinelli M, Baumann M, Piazza P, Shaham Y . The role of corticosterone in food deprivation-induced reinstatement of cocaine seeking in the rat. Psychopharmacology (Berl). 2003; 168(1-2):170-176. DOI: 10.1007/s00213-002-1200-5. View

10.

Dunn A, Berridge C . Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses?. Brain Res Brain Res Rev. 1990; 15(2):71-100. DOI: 10.1016/0165-0173(90)90012-d. View

11.

Armario A . Activation of the hypothalamic-pituitary-adrenal axis by addictive drugs: different pathways, common outcome. Trends Pharmacol Sci. 2010; 31(7):318-25. DOI: 10.1016/j.tips.2010.04.005. View

12.

Sandi C . Glucocorticoids act on glutamatergic pathways to affect memory processes. Trends Neurosci. 2011; 34(4):165-76. DOI: 10.1016/j.tins.2011.01.006. View

13.

Davis M, Redmond Jr D, Baraban J . Noradrenergic agonists and antagonists: effects on conditioned fear as measured by the potentiated startle paradigm. Psychopharmacology (Berl). 1979; 65(2):111-8. DOI: 10.1007/BF00433036. View

14.

Teoh S, Sarnyai Z, MENDELSON J, Mello N, Springer S, Sholar J . Cocaine effects on pulsatile secretion of ACTH in men. J Pharmacol Exp Ther. 1994; 270(3):1134-8. View

15.

Ulrich-Lai Y, Ostrander M, Herman J . HPA axis dampening by limited sucrose intake: reward frequency vs. caloric consumption. Physiol Behav. 2010; 103(1):104-10. PMC: 3056892. DOI: 10.1016/j.physbeh.2010.12.011. View

16.

Koob G, Heinrichs S, Pich E, Menzaghi F, Baldwin H, Miczek K . The role of corticotropin-releasing factor in behavioural responses to stress. Ciba Found Symp. 1993; 172:277-89; discussion 290-5. DOI: 10.1002/9780470514368.ch14. View

17.

Habib K, Weld K, Rice K, Pushkas J, Champoux M, Listwak S . Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates. Proc Natl Acad Sci U S A. 2000; 97(11):6079-84. PMC: 18561. DOI: 10.1073/pnas.97.11.6079. View

18.

Bakshi V, Kalin N . Corticotropin-releasing hormone and animal models of anxiety: gene-environment interactions. Biol Psychiatry. 2001; 48(12):1175-98. DOI: 10.1016/s0006-3223(00)01082-9. View

19.

Deroche V, Marinelli M, Maccari S, Le Moal M, Simon H, Piazza P . Stress-induced sensitization and glucocorticoids. I. Sensitization of dopamine-dependent locomotor effects of amphetamine and morphine depends on stress-induced corticosterone secretion. J Neurosci. 1995; 15(11):7181-8. PMC: 6578077. View

20.

Heim C, Newport D, Bonsall R, Miller A, Nemeroff C . Altered pituitary-adrenal axis responses to provocative challenge tests in adult survivors of childhood abuse. Am J Psychiatry. 2001; 158(4):575-81. DOI: 10.1176/appi.ajp.158.4.575. View